Ark Therapeutics Group

Ark Therapeutic is a healthcare group founded in 1997 and headquartered in London in the U.K. With diverse operations in the U.K; the company specializes in high-value areas of unmet medical needs. It is currently working on novel treatments for cancer and wound care and vascular disease.

The company’s pipeline of products is made up of five devices, namely Kerraboot, Kerraped, Neuropad, and Kerrama. Its pipeline also includes three pharmaceutical products in late-stage clinical development. Amidst the product development drive, Ark Therapeutics is also looking to transition from a research and development company to a commercial, revenue-generating business.

Ark therapeutics changed its name to Premier Veterinary Group in 2015. With the name change, the company expanded its footprint into the business of third party veterinary practices. The new business drive includes providing support for a preventive healthcare program for pets.

Latest Ark Therapeutics Group News

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.